Key Insights

Highlights

Success Rate

78% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 59/100

Termination Rate

10.5%

2 terminated out of 19 trials

Success Rate

77.8%

-8.7% vs benchmark

Late-Stage Pipeline

5%

1 trials in Phase 3/4

Results Transparency

43%

3 of 7 completed with results

Key Signals

3 with results78% success

Data Visualizations

Phase Distribution

8Total
Not Applicable (5)
P 1 (1)
P 2 (1)
P 4 (1)

Trial Status

Completed7
Recruiting6
Terminated2
Unknown1
Enrolling By Invitation1
Not Yet Recruiting1

Trial Success Rate

77.8%

Benchmark: 86.5%

Based on 7 completed trials

Clinical Trials (19)

Showing 19 of 19 trials
NCT00001373Recruiting

Familial Mediterranean Fever and Related Disorders: Genetics and Disease Characteristics

NCT07486752Not Yet Recruiting

BAG3-DCM Natural History Study

NCT06644742Recruiting

PKP2-ACM Natural History Study

NCT06235580RecruitingPrimary

Genotype-phenotype Characterization Study on Genetic Diseases With Immune and Neurological Dysfunctions

NCT06762002Recruiting

Impaired Type I IFN Immunity Due to Autoantibodies or a Genetic Defect: a Prospective National Cohort

NCT02717650Not ApplicableCompleted

The Alfred Step Test Exercise Protocol (A-STEP), for Adults With Cystic Fibrosis.

NCT02650622RecruitingPrimary

Genetic and Metabolic Disease in Children

NCT03211039Not ApplicableActive Not RecruitingPrimary

Perinatal Precision Medicine

NCT06260319CompletedPrimary

Decoding Developmental Disorders in Humams

NCT02917460Not ApplicableRecruitingPrimary

Rady Children's Institute Genomic Biorepository

NCT03984266Completed

The Pilot Study of High-throughput Sequencing in Neonatal Birth Defects

NCT03385876Not ApplicableEnrolling By InvitationPrimary

Rapid Whole Genome Sequencing Study

NCT02807961Phase 1TerminatedPrimary

Safety, Tolerability, Pharmacokinetics of ELX-02 in Healthy Adult Volunteers

NCT02642653Phase 4Completed

Combining Lovastatin and a Parent-Implemented Language Intervention for Fragile X Syndrome

NCT02160938CompletedPrimary

Prenatal Microarray Follow-Up Study

NCT02380729CompletedPrimary

Mutation Exploration in Non-acquired, Genetic Disorders and Its Impact on Health Economy and Life Quality

NCT02512679Phase 2Terminated

Related Hematopoietic Stem Cell Transplantation (HSCT) for Genetic Diseases of Blood Cells

NCT02657811Not ApplicableUnknown

Time-Lapse Incubation for Embryo Culture - Morphokinetics and Environmental Stability

NCT01279733CompletedPrimary

Prenatal Cytogenetic Diagnosis by Array-Based Copy Number Analysis

Showing all 19 trials

Research Network

Activity Timeline